Team

Matt shares overall responsibilities for all management and investment activities of the firm. Matt has primary responsibility for Arlington’s healthcare investments and shares responsibility for the firm’s aerospace and defense investments. Matt has closed leveraged buyouts, recapitalizations and growth equity investments representing over $3.0 billion in value during his 25 year career in private equity. Matt’s private equity experience encompasses a wide range of industries including healthcare, aerospace, defense, industrial manufacturing, specialty distribution and media. Prior to joining Arlington in 2001, Matt worked at Stonington Partners, a $1.0 billion private equity fund established in 1994 by the principals of Merrill Lynch Capital Partners. At Stonington, Matt worked on several healthcare transactions including Packard BioScience Corporation and Obagi Medical Products. Both companies ultimately completed initial public offerings before successful sale transactions. Matt’s responsibilities at Stonington included originating and conducting due diligence of investment opportunities, structuring and negotiating transactions, arranging public and private debt financing, designing management incentive plans and participating in portfolio company management and realizations. Matt was also directly involved in the monitoring and realization of Merrill Lynch Capital Partners investments.

Matt earned an M.B.A. from the Stanford Graduate School of Business and graduated summa cum laude from Duke University with a B.A. in Economics. He currently serves on the Executive Committee of the Duke Cancer Institute’s Board of Advisors.

Matt currently serves on the Board of Directors of TEAM Technologies, Inc., AVS Bio, Everest Clinical Research, Grand River Aseptic Manufacturing, Millstone Medical Outsourcing, and Riverpoint Medical. Matt has previously been a member of the Board of Directors of Advanced Health Media, Avalign Technologies, Cambridge Major Laboratories, Chandler/May, Cherry Creek Radio, Consolidated Precision Products, Endeavor Robotics, Main Line, MB Aerospace, Micron Technologies, Molecular Products, New Vision Group, Ontario Systems, Tex Tech Industries and United Flexible.

Michael shares overall responsibilities for all management and investment activities of the firm. Michael joined upon Arlington’s formation in 1999. Michael has primary responsibility for the firm’s government services investments and shares responsibility for the firm’s software and business services investments. Michael has over 25 years of private equity and merger and acquisition transactional experience having been involved in over 50 transactions.

Prior to Arlington, Michael worked at Lazard Frères & Co. based out of New York in the Telecommunications and Technology practice, where he focused on advising corporate clients on mergers and acquisitions. Michael’s transaction experience includes MCI Communications’ $43 billion merger with WorldCom – which at one point was the largest non-bank transaction of all-time.

Michael received an A.B. magna cum laude from Harvard College.

Michael currently serves on the Board of Directors of Avenu Insights & Analytics, Exostar, Integrated Data Services, Intellectual Technology, Inc., TRP Infrastructure, and Tyto Athene. Michael previously served on the Board of Directors of Apogen Technologies, BlueHalo, Centauri, Compusearch Software Systems, J&J Worldwide Services, Novetta Solutions, MicroPact, Polaris Alpha, Quantum Spatial, SECOR International, SignalTree Solutions, Systems Planning & Analysis, and Zemax.

Peter shares overall responsibilities for all management and investment activities of the firm. Peter has primary responsibility for Arlington’s aerospace/defense investments and shares responsibility for the firm’s healthcare investments. Peter has over 27 years of private equity, public equity, and merger and acquisition transactional experience and has completed 40 transactions in a variety of industries representing over $4.0 billion in aggregate enterprise value. Prior to joining Arlington in 2002, Peter worked at The Carlyle Group, a Washington, D.C.-based global private equity firm with approximately $200 billion of committed capital under management, and Capitol Partners, a Washington, D.C.-based private equity firm focused on technology, scale and infrastructure-intensive markets. As a Managing Partner with shared overall management responsibilities and Co-Chief Investment Officer at Capitol Partners, Peter built the firm’s healthcare practice and successfully sourced and executed numerous transactions.

While at Carlyle, Peter was part of the core aerospace/defense group and was part of the original healthcare buyout team. At Carlyle, Peter successfully closed over $1 billion of transactions.

Peter’s principal investing experience also includes work at Fayez Sarofim & Co., a Houston-based public equity investment firm with over $35 billion under management. While at Fayez Sarofim, Peter evaluated and made investments in the airline and automotive aftermarket industries. Peter’s transactional experience also includes numerous merger and acquisition transactions and initial public offerings as an investment banker at Donaldson, Lufkin & Jenrette and at Peers & Co., a subsidiary of the Long Term Credit Bank of Japan.

Peter’s private equity and transactional experience is complemented by his operating experience in founding, developing and running iFINANCE, a venture capital funded credit infrastructure company that provides solutions to merchants and financial institutions.

Peter earned an M.B.A. with an emphasis on finance from the Harvard Business School and an B.A. from Stanford University.

Peter is currently on the Board of Directors of Kinetic Engine Systems, Forged Solutions Group, Keel, Qarbon Aerospace, Radius Aerospace, Stellant Systems, Tex Tech Industries and Verus Aerospace. Peter has previously been a member of the Board of Directors of Advanced Health Media, Avalign Technologies, Cambridge Major Labs, Chandler/May, Consolidated Precision Products, Endeavor Robotics, MB Aerospace, Molecular Products, Ontario Systems, Quantum Spatial, SECOR International, TSI Group, and United Flexible.

David shares overall responsibilities for all management and investment activities of the firm. David joined Arlington in 2006 and is responsible for investing in the government contracting, technology-enabled business services and software and IT services sectors. David has over 18 years of private equity and merger and acquisition transactional experience having been involved in over 60 transactions. Prior to joining Arlington, David worked in Deutsche Bank’s Financial Sponsors Group in New York. While at Deutsche Bank, David worked on the origination, diligence, structuring, and financing of leveraged buyouts, including Blackstone’s acquisition of New Skies Satellites, Kelso’s acquisition of Insurance Auto Auctions, Hicks Muse’s acquisition of Swett & Crawford, and Carlyle, CD&R, and Merrill Lynch Private Equity’s $15.0 billion buyout of Hertz. Since joining Arlington, David has completed more than 50 acquisitions including BlueHalo, Cambridge Major Labs, Centauri, Compusearch Software Systems, Eqlipse Technologies, Micron Technologies, Novetta Solutions, Polaris Alpha, Quantum Spatial and Systems Planning and Analysis. Prior to Deutsche Bank, David worked as a management consultant focused on the U.S. Intelligence Community.

David graduated cum laude, with an A.B. in Economics from Georgetown University.

David currently serves on the Board of Directors at BlueHalo, Eqlipse Technologies, and Systems Planning and Analysis. David previously served on the Board of Directors of Cambridge Major Labs, Centauri, Micron Technologies, Novetta Solutions, Polaris Alpha, and Quantum Spatial.

Malcolm joined Arlington in 2014 and is responsible for investing in the healthcare sector. Prior to joining Arlington, Malcolm was a Vice President at Avista Capital Partners where he focused primarily on investments in the healthcare industry. Prior to Avista, Malcolm was an Associate at Oak Hill Capital Partners where he was responsible for investments in the firm’s Business and Financial Services industry group. Malcolm also worked at Bear, Stearns & Co. in its Leveraged Finance group.

Malcolm earned an M.B.A. degree from Harvard Business School and holds a B.S. degree, with distinction, from the University of Virginia.

Malcolm currently serves on the Board of Directors of Afton Scientific, AVS Bio, Everest Clinical Research, and Grand River Aseptic Manufacturing. Malcolm has previously been a member of the Board of Directors of Avalign Technologies, MicroPact, Molecular Products, and Ontario Systems.

Henry joined Arlington in 2018. Prior to joining Arlington, Henry was an Associate at The Carlyle Group where he focused on buyout and strategic minority investments in the aerospace, defense, and government services sectors. Prior to Carlyle, Henry was an Analyst at Morgan Stanley in its industrials investment banking group where he advised clients on a variety of M&A and capital markets transactions.

Henry holds an M.B.A. from Harvard Business School and a B.B.A. in Finance, summa cum laude, from The College of William & Mary.

Henry currently serves on the Board of Directors of Afton Scientific, BlueHalo, Eqlipse Technologies, Forged Solutions Group, Grand River Aseptic Manufacturing, and Qarbon Aerospace.

Gordon joined Arlington as a Vice President in 2018 and now serves as a Principal. Prior to joining Arlington, Gordon was at Harvest Partners where he focused on investments in the industrials and business services sectors. Before Harvest, Gordon was an Associate at Court Square Capital Partners where he was responsible for investments in the firm’s Industrials industry group. Gordon also worked at Deutsche Bank in its Consumer and Business Services Group.

Gordon earned an M.B.A. from The Wharton School of the University of Pennsylvania and holds a B.B.A. in Finance from the College of William and Mary.

Gordon currently serves on the Board of Directors of Millstone Medical Outsourcing, Riverpoint Medical, Tex Tech Industries, Tyto Athene, and TEAM Technologies, Inc. Gordon previously served on the Board of Directors for J&J Worldwide Services, Inc.

Bilal joined Arlington Capital Partners in 2015 and focuses on investing in the healthcare, business services, software, IT, and aerospace sectors. He is responsible for all aspects of the investment process including sourcing, diligence, transaction structuring, financing, and executing post-closing growth and add-on acquisition strategies. Bilal has executed several private equity transactions across a number of industries.

Prior to joining Arlington, Bilal worked at H.I.G. Capital, where he focused on private equity buyout opportunities ranging from $150 million to over $1 billion in enterprise value. Prior to that, Bilal was a member of the Leveraged Finance Group at Bank of America Merrill Lynch, where he covered a wide range of industries, including business services, healthcare, and manufacturing.

Bilal received his M.B.A. degree from Harvard Business School and holds a B.S. degree in Commerce from the University of Virginia.

Bilal currently serves on the Board of Directors of Avenu Insights & Analytics, Kinetic Engine Systems, Verus Aerospace, Everest Clinical Research, Radius Aerospace and TRP Infrastructure Services. Bilal previously served on the Board of Directors of United Flexible and Zemax.

Ben joined Arlington in 2014. Prior to joining Arlington, Ben worked for Jefferies’ Aerospace, Defense, and Government Services investment banking group. While at Jefferies, Ben advised clients on a wide range of transaction activity, including leveraged buyouts, strategic M&A and debt financings. Ben also held summer positions with Raytheon as a co-op and holds a clearance.

Ben graduated cum laude from Georgetown University where he received a B.S. in Finance and a minor in Economics.

Ben serves on the Board of Directors of Exostar, Integrated Data Services, Keel, Stellant Systems, and Systems Planning and Analysis. Ben previously served on the Board of Directors of Centauri, Endeavor Robotics, and Octo, and worked on the firm’s past investments in MicroPact, Novetta, and Polaris Alpha.

Chris joined Arlington in 2021. In his role, Chris oversees Arlington’s capital markets activities related to new investments and existing portfolio companies. Additionally, Chris is responsible for managing and helping grow the firm’s lending relationships with investment banks, direct lenders, and other capital providers. Prior to joining Arlington, Chris spent his entire career at RBC Capital Markets, where he worked in a variety of leveraged finance roles including capital markets, origination, and sales & trading. While at RBC Capital Markets, Chris advised clients on a wide range of debt financings, including leveraged buyouts, refinancing, and recapitalizations.

Chris graduated cum laude from the McDonough School of Business at Georgetown University with a B.S. in Finance and a minor in International Business.

Chris Aguemon joined Arlington Capital Partners in 2024. Prior to joining Arlington, Chris was an investor at TPG Capital, focusing on the firm’s Industrials and Services practices. Previously, Chris also worked in investment banking at Morgan Stanley, where he advised clients on different types of transactions including mergers & acquisitions, equity and debt offerings, corporate carve-outs, and activism defense. Chris is also a Signal Officer in the U.S. Army Reserves with active duty experiences that include a CENTCOM deployment.

Chris holds a B.A. in Government from Dartmouth College and an M.B.A. from Harvard Business School where he was a Loring Fellow and a Toigo Fellow.

Nick joined Arlington in 2018. Prior to joining Arlington, Nick worked for Accel-KKR, a software-focused private equity firm. Previously, Nick also worked at Bank of America Merrill Lynch where he worked on their Technology M&A team, advising both buy-side and sell-side clients.

Nick holds a B.A. in Business-Economics from UCLA, cum laude, and an M.B.A from the Wharton School of Business, where he graduated with Honors

Nick currently serves on the Board of Directors of Everest Clinical Research, Exostar, Intellectual Technology Inc, and TEAM Technologies. Nick previously worked on Arlington’s investments in BlueHalo, J&J Worldwide, Molecular Products, and Octo Consulting.

Diana joined Arlington as a Vice President in 2024.  Prior to joining Arlington, Diana was a Vice President at The Vistria Group where she focused on business services and software investments in the education and government sectors.  Before Vistria, Diana worked at Francisco Partners, where she was responsible for technology and software investments in healthcare IT and consumer internet sectors. Previously, Diana was a private equity associate at the CIM Group and an investment banking analyst at Deutsche Bank’s Leveraged Finance Group.

Diana received a B.S. in Finance and Politics with a minor in Math, cum laude, from New York University’s Stern School of Business.  She earned her M.B.A. from The Wharton School and her M.P.A. from the Harvard Kennedy School.

Kevin joined Arlington as an Associate in 2021. Prior to joining Arlington, Kevin worked at Credit Suisse in the Financial Sponsors Group, where he supported sponsor-backed transactions and leveraged finance execution processes across a range of industries. Kevin also worked at Thayer Street Partners, a private investment firm that provides flexible growth capital solutions to technology-enabled financial and business services companies.

Kevin holds a B.S. degree in Commerce from the University of Virginia.

Diana joined Arlington as an Associate in 2022. Prior to joining Arlington, Diana worked at Bank of America in the Leveraged Finance Group, where she also completed two summer internships. While at Bank of America, Diana advised clients on leveraged buyouts and other debt financing transactions across a variety of industries, including healthcare and telecommunications.

Diana graduated cum laude from Georgetown University, where she received a B.S. in Finance and Accounting and a minor in English.

Lexy joined Arlington in 2024. Prior to joining Arlington, Lexy was an Associate at BPOC where she focused on investments in the Healthcare sector. Before BPOC, Lexy was at LFM Capital, where she concentrated on Manufacturing investments. Lexy also worked at Houlihan Lokey in its Aerospace, Defense, and Government Services investment banking group.

Lexy holds a B.B.A. in Finance from the University of Notre Dame.

Yash joined Arlington as an Associate in 2021. Prior to joining Arlington, Yash was a member of the Healthcare Investment Banking Group at Bank of America Merrill Lynch, where he focused on the life sciences, medical technology, and healthcare services industry verticals. While at BofAML, Yash advised strategics and financial sponsors on mergers & acquisitions, leveraged buyouts, and capital markets transactions.

Yash received a B.S. in Biophysics from Duke University along with minors in History and Finance.

Andy joined Arlington as an Associate in 2022. Prior to joining Arlington, Andy worked at Bank of America Merrill Lynch in the Leveraged Finance Group, where he also completed a summer internship. While at BofAML, Andy advised clients on leveraged buyout, dividend recapitalization, and other debt financing transactions across a variety of industries, including business services, consumer & retail, diversified industrials and healthcare.

Andy graduated magna cum laude from Washington and Lee University where he received a B.S. in Accounting.

Harrison joined Arlington in 2024 as an Associate. Prior to joining Arlington, Harrison was an Analyst at Greenbriar Equity Group, a private equity firm focusing on buyout investments in the supply chain, manufacturing, and business services sectors.

Harrison received a B.A. in Economics and Government magna cum laude from Georgetown University.

Carter joined Arlington in 2023 as an Associate. Prior to joining Arlington, Carter was an investment banking Analyst at UBS in the Financial Sponsors & Leveraged Finance Group where he also completed a summer internship. While at UBS, Carter advised clients on leveraged buyout and other debt financing transactions across a variety of industries, including business services, diversified industrials, consumer & retail and financial institutions.

Carter graduated summa cum laude from Wake Forest University where he received a B.S. in Finance.

Nick joined Arlington in 2024 as an Associate. Prior to joining Arlington, Nick was an investment banking Analyst at Bank of America in the Financial Institutions Group, where he also completed a summer internship. While at Bank of America, Nick focused on the execution of mergers & acquisitions and capital markets transactions for traditional and alternative asset management firms.

Nick graduated summa cum laude from The College of William & Mary where he received a B.B.A. in Finance.

John joined Arlington as an Associate in 2024. Prior to joining Arlington, John worked at Bank of America in the Leveraged Finance Group, where he also completed a summer internship. While at BofA, John focused on executing debt financings across a variety of industries, including business services, aerospace, and consumer & retail.

John graduated, with distinction, from the University of Virginia with a B.S. in Commerce and a second major in Statistics.

Rahul joined Arlington in 2023 as an Associate. Prior to joining Arlington, Rahul was an investment banking Analyst at J.P. Morgan in the Financial Institutions Group where he focused on executing mergers and acquisitions as well as debt and equity capital offerings for specialty finance companies.

Rahul holds a B.S. in Commerce degree from the University of Virginia.

Kunaal joined Arlington in 2024 as an Associate. Prior to joining Arlington, Kunaal worked at William Blair in the Aerospace, Defense, and Government Services investment banking group.

Kunaal graduated magna cum laude from Dartmouth College where he received a B.A. in Economics and a minor in Mathematics.

Brian Foist joined Arlington in 2021 as Chief Administrative Officer and Chief Compliance Officer.   He is responsible for the management of the firm’s administrative and compliance operations.   Prior to joining Arlington, Brian spent five years as the CFO and CCO of Northlane Capital Partners.  Before Northlane, Brian was the COO, CFO, and CCO of Global Environment Fund for over 15 years.

Brian received his B.A. in Finance, and a minor in Economics from Xavier University and is a CFA Charterholder.

Jackie joined Arlington in 2023 as Head of Investor Relations. Prior to joining Arlington, Jackie was the Head of Investor Relations at JAB, a privately held global investment company focused on consumer goods and services with over $50bn in total managed capital. Previously she served as Principal, Investor Relations & Marketing at JMI Equity, a growth equity firm focused on investing in leading software companies. She also spent time at Cambridge Associates and General Atlantic. Jackie started her career as an investment banking analyst at UBS.

Jackie earned an M.B.A. from Harvard Business School and a B.A. from Columbia University.

Christiana joined Arlington in 2022 as Vice President of Finance. Prior to joining Arlington, Christiana was a Fund Accounting Manager at Sands Capital Ventures where she was responsible for accounting, financial analysis, and reporting for the private market investing strategies. Christiana’s private equity experience includes providing fund administration services as a manager at Venture Management Services and serving in the role of Assistant Controller – Funds at Global Environment Fund. Christiana began her career in PricewaterhouseCoopers’s tax practice.

Christiana holds a B.S. in Commerce degree with concentration in Accounting from the University of Virginia and is a Certified Public Accountant licensed in the Commonwealth of Virginia.

Kelsey joined Arlington in 2023 as Vice President of Investor Relations. Prior to joining Arlington, Kelsey was a Vice President and the Director of Communications at HCI Equity Partners where she was an integral part of the firm’s investor relations team, responsible for leading the firm’s marketing, communications and public relations initiatives.  Kelsey began her career at The Advisory Board Company.

Kelsey holds a B.A. degree in Journalism from the University of Georgia

Chris joined Arlington in 2022 as Senior Finance Manager. Prior to joining Arlington, Chris was a Manager in the assurance practice at PricewaterhouseCoopers’ Boston office where he was responsible for auditing private funds and corporate entities within the financial services sector.

Chris holds a B.S. in Accounting degree from Bentley University and an M.S. in Accounting degree from the University of Connecticut and is a Certified Public Accountant licensed in the states of Maryland and Massachusetts.

John joined Arlington in 2023 as Senior Tax Manager. Prior to joining Arlington, John was a Manager in Deloitte’s Business Tax Services practice. While at Deloitte, John worked primarily with private equity clients and operating partnerships in variety of industries.

John holds a B.B.A in Accountancy from the University of Notre Dame and is a Certified Public Accountant licensed in the state of Illinois and the District of Columbia.

Aron joined Arlington in 2023 as a fund accoutant. Prior to joining Arlington, Aron was a fund accountant in the fund administration division of Northern Trust. At Northern Trust, he was responsible for preparation and review of financial statements and partners’ capital account statements.

Aron holds a B.S. in Finance from Ohio State University.

Haley joined Arlington in 2023 as Office Operations Manager. Prior to joining Arlington, Haley was Chief of Staff at Leading Authorities, Inc. where she was responsible for operations and managing the administrative staff.

Haley holds a B.A. in Political Science & Philosophy from Virginia Tech.

Email: brogers@arlingtoncap.com
Office: 202-839-1773

Email: hrothe@arlingtoncap.com
Office: 202-839-0338